157 related articles for article (PubMed ID: 28043148)
21. [Exploration of differential expressed genes involved in the development and progression of hepatocellular carcinoma using oligo microarray].
Liu XF; Shi RH; Gao HJ; Zhu H; Qin SK; Wang XH
Zhonghua Gan Zang Bing Za Zhi; 2006 Nov; 14(11):824-7. PubMed ID: 17125609
[TBL] [Abstract][Full Text] [Related]
22. Identification of MicroRNAs and target genes involvement in hepatocellular carcinoma with microarray data.
Wang D; Tan J; Xu Y; Tan X; Han M; Tu Y; Zhu Z; Zen J; Dou C; Cai S
Hepatogastroenterology; 2015; 62(138):378-82. PubMed ID: 25916067
[TBL] [Abstract][Full Text] [Related]
23. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.
Yin F; Shu L; Liu X; Li T; Peng T; Nan Y; Li S; Zeng X; Qiu X
J Exp Clin Cancer Res; 2016 Aug; 35(1):127. PubMed ID: 27567667
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC).
Xu W; Huang H; Yu L; Cao L
Med Oncol; 2015 Apr; 32(4):96. PubMed ID: 25731616
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.
Liang L; Zeng JH; Wang JY; He RQ; Ma J; Chen G; Cai XY; Hu XH
Pathol Res Pract; 2017 Dec; 213(12):1494-1509. PubMed ID: 29113686
[TBL] [Abstract][Full Text] [Related]
26. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
Li L; Lei Q; Zhang S; Kong L; Qin B
Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
[TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.
Yan H; Li Z; Shen Q; Wang Q; Tian J; Jiang Q; Gao L
Pathol Res Pract; 2017 Apr; 213(4):316-321. PubMed ID: 28238542
[TBL] [Abstract][Full Text] [Related]
28. Gene expression signature of human HepG2 cell line.
Costantini S; Di Bernardo G; Cammarota M; Castello G; Colonna G
Gene; 2013 Apr; 518(2):335-45. PubMed ID: 23357223
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Sang L; Wang XM; Xu DY; Zhao WJ
World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
[TBL] [Abstract][Full Text] [Related]
30. Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
Cheng Y; Ping J; Chen J
Pathol Oncol Res; 2018 Jul; 24(3):507-514. PubMed ID: 28669080
[TBL] [Abstract][Full Text] [Related]
31. [Bioinformatics analysis of key genes and prognosis-related genes during the onset of hepatocellular carcinoma].
Zhou ZW; Zhou XG; Liu YC; Qiu MQ; Wen QP; Zhou ZH; Jiang YJ; Feng SX; Yu HP
Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):686-691. PubMed ID: 32911908
[No Abstract] [Full Text] [Related]
32. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
Wang J; Tian Y; Chen H; Li H; Zheng S
Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.
Agarwal R; Narayan J; Bhattacharyya A; Saraswat M; Tomar AK
Cancer Genet; 2017 Oct; 216-217():37-51. PubMed ID: 29025594
[TBL] [Abstract][Full Text] [Related]
34. Identification of dysfunctional biological pathways and their synergistic mechanism in hepatocellular carcinoma process.
Liang J; Lv J; Liu Z
Exp Mol Pathol; 2015 Jun; 98(3):540-5. PubMed ID: 25805103
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Transcription Factor-Related Regulatory Networks Based on Bioinformatics Analysis and Validation in Hepatocellular Carcinoma.
Liu S; Yao X; Zhang D; Sheng J; Wen X; Wang Q; Chen G; Li Z; Du Z; Zhang X
Biomed Res Int; 2018; 2018():1431396. PubMed ID: 30228980
[TBL] [Abstract][Full Text] [Related]
36. Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma.
Chen J; Qian Z; Li F; Li J; Lu Y
Gut Liver; 2017 Jan; 11(1):112-120. PubMed ID: 27458175
[TBL] [Abstract][Full Text] [Related]
37. Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis.
Xue TC; Zhang BH; Ye SL; Ren ZG
Tumour Biol; 2015 Aug; 36(8):5891-9. PubMed ID: 25712376
[TBL] [Abstract][Full Text] [Related]
38. Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis.
Zhou RS; Wang XW; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
Biomed Res Int; 2019; 2019():3065818. PubMed ID: 31236404
[TBL] [Abstract][Full Text] [Related]
39. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
40. Cross-species hybridization of woodchuck hepatitis viral infection-induced woodchuck hepatocellular carcinoma using human, rat and mouse oligonucleotide microarrays.
Wang F; Kuang Y; Salem N; Anderson PW; Lee Z
J Gastroenterol Hepatol; 2009 Apr; 24(4):605-17. PubMed ID: 19175833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]